The significance of the risk-adapted antiviral prophylaxis and modern virological diagnosis for the survival of a renal transplant;Bedeutung risikoadaptierter antiviraler Prophylaxe und moderner Virusdiagnostik fur das Organuberleben nach Nierentransplantation

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 18, 1997, Pages 565-571

  Fricke, L ^a,b   Steinhoff, J ^a,b   Hartwig Weber, I ^a,b   Bein, G ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Kreiskrankenhaus Schmalkalden   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN A; CYTOGLOBIN; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; OKT 3; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; RISK ASSESSMENT; SURVIVAL;

EID: 0030950310     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047655     Document Type: Article

References (38)

1. Balfour, H. H., B. A. Chace, J. T. Stapleton, R. L. Simmons, D. S. Fryd: A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. New Engl. J. Med. 320 (1989), 1381-1387.
2. Bein, G., A. Bitsch, J. Hoyer, H. Kirchner: The detection of human cytomegalovirus immediate early antigen in peripheral blood leucocytes. J. immunol. Meth. 137 (1991), 175-180.
3. Bein, G., A. Bitsch, J. Hoyer, J. Steinhoff, L. Fricke, H. Machnik, R. Dennin, H. Kirchner: A longitudinal prospective study of cytomegalovirus pp65 antigenemia in renal transplant recipients. Transplant int. 6 (1993), 185-190.
4. van den Berg, A. P., A. M. Tegzess, A. Scholten-Sampson, J. Schirm, M. van der Giessen, T. H. The, W. J. van Son: Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation. Transplant int. 5 (1992), 101-106.
5. Bitsch, A., H. Kirchner, R. Dupke, G. Bein: Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse transcription-polymerase chain reaction. J. infect. Dis. 167 (1993), 740-743.
6. Bitsch, A., H. Kirchner, R. Dennin, J. Hoyer, L. Fricke, J. Steinhoff, K. Sack, G. Bein: The long persistance of CMV DNA in the blood of renal transplant patients after recovery from CMV infection. Transplantation 56 (1993), 108-113.
7. Boeckh, M., R. A. Browden: Current diagnostic procedures for detection of cytomegalovirus infections. Chemother. J. 1 (1995), 5-13.
8. Checka, J. M., P. I. Terasaki: The UNOS Scientific Renal Transplant Registry. Clin. Transplant. (1992), 1-16.
9. Checka, J. M.: Outcome statistics of renal transplants with an emphasis on long-term survival. Clin. Transplant. 8 (1994), 324-327.
10. Colvin, R. B.: Cellular and molecular mechanisms of allograft rejection. Ann. Rev. Med. 41 (1990), 361-375.
11. Conti, D. J., B. M. Freed, N. Lempert: Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease. Transplant. Proc. 25 (1993), 1421-1422.
12. van Dorp, W. T., P. A. van Wieringen, E. Marselis-Jonges, C. A. Bruggeman, M. R. Daha, L. A. van Es, F. van der Woude: Cytomegalovirus directly enhances MHC class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation 55 (1993), 1367-1371.
13. Farrugia, E., T. R. Schwab: Management and prevention of cytomegalovirus infection after renal transplantation. Mayo Clin. Proc. 67 (1992), 879-890.
14. Glowacki, L. S., F. M. Smaill: Meta-analysis of immune globulin prophylaxis in transplant recipients for the prevention of symptomatic cytomegalovirus disease. Transplant. Proc. 25 (1993), 1408-1410.
15. Gulanikar, A. C., A. S. MacDonald, U. Sungurtekin, P. Belitsky: The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation 53 (1992), 323-328.
16. Hornef, M. W., G. Bein, L. Fricke, J. Steinhoff, H. J. Wagner, W. Hinderer, H. H. Sonneborn, H. Kirchner: Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation 60 (1995), 474-480.
17. Hrebinko, R., M. L. Jordan, J. S. Dummer, D. P. Hickey, R. Shapiro, C. Vivas, T. E. Starzl, R. L. Simmons, T. R. Hakala: Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplant. Proc. 23 (1991), 1346-1347.
18. Iberer, F., K. H. Tscheliessnigg, G. Halwachs, T. Auer, A. Wasler, B. Petutschnigg, H. Müller, M. Freigassner, T. Allmayr, G. Hipmaier, G. Prenner, B. Grasser: CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation. Wien. Klin. Wschr. 107 (1995), 718-722.
19. Lautenschlager, I., K. Salmela, P. Hayry: Does CMV infection affect the outcome of renal allografts? Transplant. Proc. 24 (1992), 281-282.
20. Merlino, C.: Serological follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients. G. Batteriol. Virol. 84 (1991), 41-52.
21. Metselaar, H. J., P. H. Rothbarth, R. M. Brouwer, G. J. Wenting, J. Jeekel, W. Weimar: Prevention of cytomegalovirus-related death by passive immunization. A double-blind placebo-controlled study in kidney transplant recipients treated for rejection. Transplantation 48 (1989), 264-266.
22. Morris, D. J., S. Martin, P. A. Dyer, L. Hunt, N. P. Mallick, R. W. Johnson: HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients. J. med. Virol. 41 (1993), 324-327.
23. Nast, C. C., A. Wilkinson, J. T. Rosenthal, L. Barba, P. N. Bretan, P. Beaumont, G. M. Danowitch: Differentiation of cytomegalovirus infection from acute rejection using renal allograft fine needle aspirates. J. Amer. Soc. Nephrol. 1 (1991), 1204-1211.
24. Pouteil-Noble, C., R. Ecochard, G. Landrivon, A. Donia-Maged, J. C. Tardy, S. Bosshard, S. Colon, H. Betuel, M. Aymard, J. L. Touraine: Cytomegalovirus infection - an etiological factor for rejection? A prospective study in 242 renal transplant patients. Transplantation 55 (1993), 851-857.
25. Rondeau, E., B. Bourgeon, M. N. Peraldi, O. Lang, C. Buisson, K. M. Schulte, B. Weill, J. D. Sraer: Effect of prophylactic Ganciclovir on cytomegalovirus infection in renal transplant recipients. Nephrol. Dialys. Transplant. 8 (1993), 858-862.
26. van Sasse, J. L., F. J. van der Woude, J. Thorogood, A. A. Hollander, L. A. van Es, J. J. Weening, J. H. van Bockel, J. A. Bruijn: The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 59 (1995), 1280-1285.
27. Schleibner, S., H. Schneeberger, W. Land: Rationelle Anwendung der Cytomegalie-Prophylaxe nach Nierentransplantation. Zeitschrift für Transplantationsmedizin 4 (1992), 71-73.
28. Snydman, D. R.: Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients. Transplant. Proc. 25 (1993), 25-26.
29. Steinhoff, J., A. Feddersen, W. G. Wood, G. Bein, R. Preuss, L. Fricke, K. Sack: β2-Mikroglobulinurie bei Cytomegalievirus-Infektionen nach Nierentransplantation. Dtsch. med. Wschr. 26 (1991), 1008-1012.
30. Steinhoff, J., U. Bühner, A. Feddersen, W. G. Wood, R. Preuss, L. Fricke, P. Faerber, C. Dodt, J. Hoyer, K. Sack; C-reaktives Protein im Urin. Dtsch. med. Wschr. 117 (1992), 894-899.
31. Steinhoff, J., A. Feddersen, R. Preuss, W. G. Wood, L. Fricke, J. Hoyer, K. Sack: Quantitative protein determination in urine. Diagnostic value in renal transplant recipients. Transplant. Proc. 24 (1992), 362-365.
32. Steinhoff, J., A. Feddersen, W. G. Wood, J. Hoyer, G. Bein, G. Wiedemann, L. Fricke, K. Sack: β2-Microglobulinuria as an early sign of cytomegalovirus infection following renal transplantation. Transplant int. 5 (1992), 300-302.
33. The, T. H., M. van der Ploeg, A. P. van den Berg, A. M. Vlieger, M. van der Giessen, W. J. van Son: Direct detection of cytomegalovirus in peripheral blood leukocytes. A review of the antigenemia assay and polymerase chain reaction. Transplantation 54 (1992), 193-198.
34. Ward, K. N., M. J. Sheldon, J. J. Gray: Primary and recurrent cytomegalovirus infections have different effects on human herpesvirus-6 antibodies in immunosuppressed organ graft recipients: Absence of virus cross-reactivity and evidence for virus interaction. J. med. Virol. 34 (1991), 258-267.
35. Willebrand, von, E., E. Pettersson, J. Ahonen, P. Häyry: CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 42 (1986), 364-367.
36. Winston, D. J.: Prevention of cytomegalovirus disease in transplant recipients. Lancet 346 (1995), 1380-1381.
37. Wood, W. G., D. Herhahn, J. Steinhoff, A. Feddersen, E. Schulz, K. Sack: The diagnostic relevance of specific urinary proteins after renal transplantation. Ärztl. Lab. 36 (1990), 260-267.
38. Yoshikawa, T., S. Suga, Y. Asano, T. Nakashima, T. Yazaki, Y. Ono, T. Fujita, K. Tsuzuki, S. Sugiyama, S. Oshima: A prospective study of human herpesvirus-6 infection in renal transplantation. Transplantation 54 (1992), 879-883.